Genologics has announced that the Wellcome Trust is to deploy its Geneus laboratory and data management solution for genomics, including integrations to next-generation sequencing platforms.
The Wellcome Trust Centre for Human Genetics (WTCHG) undertakes research into the genetic basis of multi-factorial diseases such as hypertension, diabetes, heart disease, infectious diseases, psychiatric disorders and multiple sclerosis.
The genomics group of the centre conducts research and development and provides a number of services for the centre and other University of Oxford groups.
Areas of interest include microarray, high-throughput quantitative gene expression, high-throughput genotyping and other specialties.
Dr Ioannis Ragoussis, head of genomics at the Wellcome Trust Centre for Human Genetics, said: 'We selected Geneus for our centralised laboratory and data management platform because of its flexibility to automate data capture from a range of genomics instruments and applications, while allowing us to more efficiently track samples and quality control results across numerous projects.' Ragoussis added: 'A primary consideration in our selection of Geneus was the platform's capability to fully integrate to our next-generation sequencing instruments from Illumina and Roche, and automatically pipeline data for downstream analysis.' Geneus is designed for the needs of genomics research facilities, and so the laboratory and data management solution can be deployed quickly to provide the centre with immediate value.
Pre-configured integrations across many instruments, including Illumina's Genome Analyser, means Geneus will improve the efficiency of the centre as well as the quality of the data.
This includes configuring the system for range of applications such as ChIP sequencing, resequencing, whole genome sequencing and genome-wide association studies.
By using Genologics's web collaboration tool, Lablink, and adaptive reporting engine, the centre will also be able to easily generate and share results with its customers.